Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,529 JPY | +0.72% | -4.44% | -12.08% |
2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
ETFs positioned on Fuji Pharma Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 19 M€ | +11.51% | ||
0.00% | 45 M€ | 0.00% | - | |
0.00% | 17 M€ | +11.76% | - | |
0.00% | 140,441 M€ | +16.69% | ||
0.00% | 63,295 M€ | +16.72% | - | |
0.00% | 20,360 M€ | +15.55% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.08% | 236M | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- 4554 Stock
- Funds and ETFs Fuji Pharma Co., Ltd.